Hiroki Kumagai

2.2k total citations
12 papers, 559 citations indexed

About

Hiroki Kumagai is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Hiroki Kumagai has authored 12 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Hiroki Kumagai's work include Adipose Tissue and Metabolism (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Neuropeptides and Animal Physiology (3 papers). Hiroki Kumagai is often cited by papers focused on Adipose Tissue and Metabolism (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Neuropeptides and Animal Physiology (3 papers). Hiroki Kumagai collaborates with scholars based in Japan, United States and India. Hiroki Kumagai's co-authors include Fumiko Takeda, S Ebashi, Tetsuya Kubota, Naoto Kubota, Masao Moroi, Takashi Kadowaki, Tetsuo Noda, Kohjiro Ueki, Kaoru Sugi and Iseki Takamoto and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Hiroki Kumagai

12 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroki Kumagai Japan	9	251	199	189	109	77	12	559
Hiroyasu Hirose Japan	10	132 0.5×	162 0.8×	136 0.7×	91 0.8×	106 1.4×	16	505
Joan Helmering United States	9	342 1.4×	105 0.5×	178 0.9×	139 1.3×	88 1.1×	11	581
Haruhisa Yamashita Japan	14	170 0.7×	55 0.3×	120 0.6×	122 1.1×	82 1.1×	29	631
Angana Gupta Rajapakse Switzerland	10	203 0.8×	81 0.4×	243 1.3×	48 0.4×	38 0.5×	11	578
Desmond Jay United States	7	201 0.8×	84 0.4×	200 1.1×	93 0.9×	76 1.0×	10	661
Therese H. Røst Norway	13	249 1.0×	101 0.5×	141 0.7×	47 0.4×	53 0.7×	18	467
Elizabeth Foot United Kingdom	12	249 1.0×	58 0.3×	184 1.0×	125 1.1×	119 1.5×	26	585
Yukihito Ishii Japan	13	104 0.4×	53 0.3×	114 0.6×	115 1.1×	80 1.0×	24	379
Roselle Gélinas Canada	15	321 1.3×	56 0.3×	166 0.9×	73 0.7×	77 1.0×	22	579
Azize Şener Türkiye	12	120 0.5×	91 0.5×	78 0.4×	33 0.3×	51 0.7×	33	542

Countries citing papers authored by Hiroki Kumagai

Since Specialization

Citations

This map shows the geographic impact of Hiroki Kumagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Kumagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Kumagai more than expected).

Fields of papers citing papers by Hiroki Kumagai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Kumagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Kumagai. The network helps show where Hiroki Kumagai may publish in the future.

Co-authorship network of co-authors of Hiroki Kumagai

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Kumagai. A scholar is included among the top collaborators of Hiroki Kumagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Kumagai. Hiroki Kumagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Kubota, Naoto, Tetsuya Kubota, Tomokatsu Iwamura, et al.. (2016). Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity. Nature Communications. 7(1). 12977–12977. 93 indexed citations

Kubota, Tetsuya, Naoto Kubota, Hiroyuki Satō, et al.. (2016). Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways. Scientific Reports. 6(1). 34707–34707. 9 indexed citations

Takahashi, Eiki, Mayumi Nakajima, Yu Omori, et al.. (2014). The discovery of potent glycine transporter type-2 inhibitors: Design and synthesis of phenoxymethylbenzamide derivatives. Bioorganic & Medicinal Chemistry Letters. 24(18). 4603–4606. 6 indexed citations

Okazaki, Seiji, Takehiro Takahashi, Tomokatsu Iwamura, et al.. (2014). HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models. Journal of Pharmacology and Experimental Therapeutics. 351(1). 181–189. 17 indexed citations

Kumagai, Hiroki, Naoto Kubota, Tetsuya Kubota, et al.. (2013). Combined treatment with low-dose pioglitazone and beraprost sodium improves glucose intolerance without causing body weight gain. Diabetology International. 4(4). 226–232. 2 indexed citations

Fujii, H., et al.. (2012). Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(23). 7036–7040. 21 indexed citations

Fujii, H., Yutaka Nishimura, Hideki Kozono, et al.. (2008). (3R)-3-Amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 18(20). 5435–5438. 30 indexed citations

Mitsudo, Koichi, et al.. (2007). Anionic WS-TEMPO-mediatory electrooxidation of alcohols in water: halide-free oxidation directed towards a totally closed system. Tetrahedron Letters. 48(51). 8994–8997. 22 indexed citations

Kubota, Naoto, Yasuo Terauchi, Tetsuya Kubota, et al.. (2006). Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and -independent Pathways. Journal of Biological Chemistry. 281(13). 8748–8755. 269 indexed citations

10.

Hayashi, Ryoji, et al.. (2006). Design and synthesis of selective α1B adrenoceptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(15). 4045–4047. 5 indexed citations

11.

Yamada, Naohiro, Hiroshi Koike, Hiroki Kumagai, et al.. (1995). Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin I2 Analogue) in the Atherosclerotic Rabbit Artery After Angioplasty. Journal of Cardiovascular Pharmacology. 25(6). 947–952. 22 indexed citations

12.

Kumagai, Hiroki, S Ebashi, & Fumiko Takeda. (1955). Essential Relaxing Factor in Muscle other than Myokinase and Creatine Phosphokinase. Nature. 176(4473). 166–166. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact